Pediatric Exclusivity Incentives Proposed In European Commission Draft Reg
A draft European Commission regulation would create a new "Pediatric Use Marketing Authorization" to encourage the study of off-patent drugs in children
You may also be interested in...
Pfizer CEO Hank McKinnell supports European drug regulation legislation that provides extended marketing exclusivity and speeds the entry of generics
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials